Cite
Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma.
MLA
Sakamoto, Ryoko, et al. “Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma.” The Journal of Investigative Dermatology, vol. 140, no. 10, Oct. 2020, p. 2060. EBSCOhost, https://doi.org/10.1016/j.jid.2020.01.031.
APA
Sakamoto, R., Kajihara, I., Miyauchi, H., Maeda-Otsuka, S., Yamada-Kanazawa, S., Sawamura, S., Kanemaru, H., Makino, K., Aoi, J., Makino, T., Fukushima, S., Masuzawa, M., Masuzawa, M., Amoh, Y., Hoshina, D., Abe, R., & Ihn, H. (2020). Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma. The Journal of Investigative Dermatology, 140(10), 2060. https://doi.org/10.1016/j.jid.2020.01.031
Chicago
Sakamoto, Ryoko, Ikko Kajihara, Hitomi Miyauchi, Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Soichiro Sawamura, Hisashi Kanemaru, et al. 2020. “Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma.” The Journal of Investigative Dermatology 140 (10): 2060. doi:10.1016/j.jid.2020.01.031.